JPRN-jRCT1080222391未知Unknown
Azilva Tablets special drug use surveillance: Long-term use
TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点目标入组 3,000 人开始时间: 2014年2月10日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Patients with a history of hypersensitivity to any of the ingredients of in azilsartan.
- •2. Patients who are pregnant or having possibilities of being pregnant
排除标准
- 未提供
研究者
相似试验
未知
Unknown
Azilva Tablets special drug use surveillance Hypertension complicated by diabetesHypertensionJPRN-jRCT1080222416TAKEDA PHARMACEUTICAL COMPANY LTD.300
已完成
不适用
Special Drug Use-results Surveillance for long term administration in adult (18 years and older) of CONCERTA, 18mg/ 27mg/ 36mg TabletsAttention deficit hyperactivity disorder (ADHD)JPRN-UMIN000015900Janssen Pharmaceutical K.K500
已完成
不适用
Special Drug Use-results Surveillance for long term administration of XEPLION (Paliperidone Palmitate 1 month formulation), 25mg/ 50mg/ 75mg/ 100mg/ 150mg syringeSchizophreniaJPRN-UMIN000018665Janssen Pharmaceutical K.K.1,050
招募中
不适用
Special drug use Surveillance for EFIENT Tablets- Patient with ischemic cerebrovascular disease with a high risk of ischemic strokeIschemic cerebrovascular disease (associated with large-artery atherosclerosis or small-vessel occluJPRN-jRCT2031220131Matsuoka Yomei1,200
招募中
不适用
ZELBORAF Special Drug Use Surveillance (Malignant Melanoma)Malignant MelanomaJPRN-UMIN000016583Chugai Pharmaceutical Co. Ltd.500